Quick Takeaways
- Aberdeen Group plc filed SCHEDULE 13G for IMMUNIC, INC common stock (IMUX).
- Disclosed ownership: 8.6%.
- Date of event: 30 Jun 2025.
Aberdeen Group plc - 30 Jun 2025 SCHEDULE 13G Report for IMMUNIC, INC common stock (IMUX)
- Filing Manager
- Aberdeen Group plc
- Reporting Manager
- Aberdeen Group plc
- Security
- IMMUNIC, INC common stock
- Symbol
- IMUX
- Shares outstanding
- 95,826,351 shares
- Disclosed Ownership
- 8,243,941 shares
- Ownership
- 8.6%
- Form type
- SCHEDULE 13G
- Filing time
- 31 Jul 2025, 15:46:59 UTC
- Date of event
- 30 Jun 2025
- Next filing
- 02 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Aberdeen Group plc disclosed 8.6% ownership in IMMUNIC, INC common stock (IMUX) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 31 Jul 2025, 15:46.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Aberdeen Group plc | 8.6% | 8,243,941 | 0 | 8,243,941 | L.Beaton | Lyn Beaton, Major Shareholding Reporting Analyst | |
| abrdn Inc | 8.6% | 8,243,941 | 0 | 8,243,941 | L.Beaton | Lyn Beaton, Major Shareholding Reporting Analyst |